SCHEMBL7817324

SCHEMBL7817324

CCOC(=O)C1CNc2ccc(Cl)cc2O1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.52
KMT2A Q03164 6/20 0.45
MEN1 O00255 5/20 0.45
ALDH1A1 P00352 2/20 0.44
CYP4F2 P78329 1/20 0.43
CYP4A11 Q02928 1/20 0.43
HPGD P15428 2/20 0.42
MAPT P10636 2/20 0.39
LMNA P02545 2/20 0.39
HSD17B10 Q99714 1/20 0.39
RAB9A P51151 1/20 0.38
ATM Q13315 1/20 0.38
ALPG P10696 1/20 0.38
TSHR P16473 1/20 0.38
HTT P42858 1/20 0.38
ADAMTS5 Q9UNA0 1/20 0.38
ATF4 P18848 1/20 0.37
MAPK1 P28482 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29853923 1.00 POLB (0.52) POLBKMT2AMEN1ALDH1A1CYP4F2
SCHEMBL3353094 0.90 POLB (0.55) POLBKMT2AMEN1ALDH1A1CYP4F2
SCHEMBL29527171 0.90 POLB (0.55) POLBKMT2AMEN1ALDH1A1CYP4F2
SCHEMBL2577554 0.87 HSD17B10 (0.48) POLBKMT2AMEN1ALDH1A1CYP4F2
SCHEMBL24378152 0.85 KMT2A (0.47) POLBKMT2AMEN1ALDH1A1CYP4F2
SCHEMBL12850374 0.85 CYP4F2 (0.43) POLBKMT2AMEN1ALDH1A1CYP4F2
SCHEMBL3355610 0.85 POLB (0.43) POLBKMT2AMEN1ALDH1A1CYP4F2
SCHEMBL3358045 0.84 ALDH1A1 (0.45) POLBKMT2AMEN1ALDH1A1CYP4F2
SCHEMBL24378131 0.82 CYP4F2 (0.46) POLBKMT2AMEN1ALDH1A1CYP4F2
SCHEMBL8566458 0.82 HPGD (0.61) POLBKMT2AMEN1ALDH1A1CYP4F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4017586-A1 ENZYME INHIBITORS Kalvista Pharmaceuticals Limited (GB) 2022-06-29 EP disclosed
CN-114269431-A Enzyme inhibitors 卡尔维斯塔制药有限公司 2022-04-01 CN disclosed
WO-2021032933-A1 ENZYME INHIBITORS KALVISTA PHARMACEUTICALS LIMITED (GB) 2021-02-25 WO disclosed
WO-2021032933-A1 ENZYME INHIBITORS KALVISTA PHARMACEUTICALS LIMITED (GB) 2021-02-25 WO disclosed
EP-0894796-B1 Imidazolines substituted with a heterocyclic ring as alpha-2 antagonists ADIR (FR) 2001-06-06 EP disclosed
US-6057317-A Heterocyclic compounds ADIR ET COMPAGNIE (FR) 2000-05-02 US disclosed
EP-0894796-A1 Imidazolines substituted with a heterocyclic ring as alpha-2 antagonists ADIR ET COMPAGNIE (FR) 1999-02-03 EP disclosed